State
19,704 recalls have nationwide distribution and so reach Michigan. 0 additional recalls listed Michigan specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Michigan consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Medline Industries has recalled the GYN Laparoscopy Pack (Model DYNJ41257F, Lot 25GBL423) because its regulatory clearances for certain components—including Control Syringes, Guidewires, and High-Pressure Tubing—have been rescinded.
Premier Dental Products is recalling Monsel's Solution (ferric subsulfate) 8 mL vials because the expiration date on the vial itself is printed with an extra digit (2709114 instead of 270914). The carton expiration date is correct.
Pending LLM rewrite. Source: CPSC 26434.
Pending LLM rewrite. Source: CPSC 26432.
Pending LLM rewrite. Source: CPSC 26440.
Pending LLM rewrite. Source: CPSC 26438.
Pending LLM rewrite. Source: CPSC 26430.
Pending LLM rewrite. Source: CPSC 26429.
Pending LLM rewrite. Source: CPSC 26433.
Pending LLM rewrite. Source: CPSC 26431.
Pending LLM rewrite. Source: CPSC 26436.
Pending LLM rewrite. Source: CPSC 26437.
Pending LLM rewrite. Source: CPSC 26435.
Pending LLM rewrite. Source: FDA_DRUG D-0510-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1816-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1797-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0451-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1825-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0531-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0465-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0458-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1806-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1821-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0449-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0477-2026.